This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delon, A.
Right arrow Articles by Couet, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delon, A.
Right arrow Articles by Couet, W.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 1999, p. 1511-1515, Vol. 43, No. 6
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Pharmacokinetic-Pharmacodynamic Contributions to the Convulsant Activity of Fluoroquinolones in Rats

Annie Delon, Serge Bouquet, Francois Huguet, Valerie Brunet, Philippe Courtois, and William Couet*

EA 1223, Faculté de Médecine & Pharmacie, Universite de Poitiers, Poitiers, France

Received 11 September 1998/Returned for modification 30 January 1999/Accepted 7 March 1999

The in vivo convulsant activities in rats of five representative fluoroquinolones (FQs), norfloxacin, enoxacin, sparfloxacin, fleroxacin, and pefloxacin, were compared. The experimental approach allowed distinction between the drugs' ability to reach the pharmacological receptors at the level of the central nervous system (pharmacokinetic contribution) and their ability to interact with these receptors (pharmacodynamic contribution). The presence of a methyl group on the piperazine moiety decreased the pharmacodynamic contribution to the convulsant activity by severalfold, and the ratios of concentrations of the FQs in cerebrospinal fluid (CSF) to concentrations of unbound FQs in plasma varied from about 5 to 75% as a function of lipophilicity. Interestingly, FQs with the highest intrinsic convulsant activities had the lowest levels of diffusion in CSF and vice versa. This in vivo approach provides information complementary to that of in vitro experiments and should be recommended for early preclinical assessment of a new FQ's epileptogenic risk.


* Corresponding author. Mailing address: Laboratoire de Pharmacie Galénique et Biopharmacie, Faculté de Médecine & Pharmacie, 34 rue du Jardin des Plantes, 86005 Poitiers Cédex, France. Phone: (33-5) 49.45.43.79. Fax: (33-5) 49.45.43.78. E-mail: William.Couet{at}campus.univ-poitiers.fr.


Antimicrobial Agents and Chemotherapy, June 1999, p. 1511-1515, Vol. 43, No. 6
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Marchand, S., Forsell, A., Chenel, M., Comets, E., Lamarche, I., Couet, W. (2006). Norfloxacin Blood-Brain Barrier Transport in Rats Is Not Affected by Probenecid Coadministration. Antimicrob. Agents Chemother. 50: 371-373 [Abstract] [Full Text]  
  • Chenel, M., Barbot, A., Dupuis, A., Mimoz, O., Paquereau, J., Bouquet, S., Couet, W. (2003). Pharmacokinetic-Pharmacodynamic Modeling of the Electroencephalogram Effect of Norfloxacin in Rats. Antimicrob. Agents Chemother. 47: 1952-1957 [Abstract] [Full Text]  
  • Smolders, I., Gousseau, C., Marchand, S., Couet, W., Ebinger, G., Michotte, Y. (2002). Convulsant and Subconvulsant Doses of Norfloxacin in the Presence and Absence of Biphenylacetic Acid Alter Extracellular Hippocampal Glutamate but Not Gamma-Aminobutyric Acid Levels in Conscious Rats. Antimicrob. Agents Chemother. 46: 471-477 [Abstract] [Full Text]  
  • Marchand, S., Pariat, C., Boulanger, A., Bouquet, S., Couet, W. (2001). A pharmacokinetic/pharmacodynamic approach to show that not all fluoroquinolones exhibit similar sensitivity toward the proconvulsant effect of biphenyl acetic acid in rats. J Antimicrob Chemother 48: 813-820 [Abstract] [Full Text]  
  • Dupuis, A., Couet, W., Paquereau, J., Debarre, S., Portron, A., Jamois, C., Bouquet, S. (2001). Pharmacokinetic-Pharmacodynamic Modeling of the Electroencephalogram Effect of Imipenem in Healthy Rats. Antimicrob. Agents Chemother. 45: 1682-1687 [Abstract] [Full Text]